INGALLS & SNYDER LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 170 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is 2.31 and the average weighting 0.6%.

Quarter-by-quarter ownership
INGALLS & SNYDER LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$278
+159.8%
16,830
-0.3%
0.01%
+160.0%
Q2 2023$107
+84.5%
16,880
-0.8%
0.01%
+66.7%
Q1 2023$58
-51.7%
17,011
-18.0%
0.00%
-57.1%
Q4 2022$120
-99.9%
20,756
-5.6%
0.01%
-41.7%
Q3 2022$207,000
-60.4%
21,981
-6.2%
0.01%
-55.6%
Q2 2022$523,000
-59.6%
23,437
-0.5%
0.03%
-53.4%
Q1 2022$1,295,000
+165.4%
23,547
+219.0%
0.06%
+163.6%
Q4 2021$488,000
-1.6%
7,382
+25.0%
0.02%
-4.3%
Q3 2021$496,0005,9050.02%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders